Skip to main content
. 2019 Sep 25;5(1):35–42. doi: 10.1089/pancan.2019.0012

FIG. 1.

FIG. 1.

Study design for phase I. aInitially, 6 patients were enrolled at dose level 1, but the cohort was expanded to 12 patients based on investigators' recommendation. 5-FU, 5-fluorouracil; CI, continuous infusion; DLT, dose-limiting toxicity; nab-P, nab-paclitaxel.